Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» heart disease
heart disease
Novo Nordisk says Wegovy can help heart disease patients—and not just because it produces weight loss
Fierce Pharma
Mon, 11/13/23 - 12:08 pm
Novo Nordisk
Wegovy
heart disease
cardiovascular disease
clinical trials
First look at Verve study data offer base editing ‘proof of principle’
BioPharma Dive
Sun, 11/12/23 - 09:27 pm
Verve Therapeutics
heart disease
gene editing
Verve gets FDA green light to run base editing study in US
BioPharma Dive
Mon, 10/23/23 - 05:01 pm
Verve Therapeutics
FDA
gene editing
heart disease
clinical trials
Pfizer Lawsuit Seeks to Block Generic Copy of Heart Disease Blockbuster
BioSpace
Mon, 08/14/23 - 06:47 pm
Pfizer
generics
legal
Vyndamax
heart disease
patents
tafamidis
Dexcel Pharma
Evox Therapeutics to advance gene therapy for treatment of heart disease
Biopharma Reporter
Mon, 08/7/23 - 10:46 am
Evox Therapeutics
gene therapy
Mount Sinai
heart disease
cardiomyocytes
Agepha Pharma gets ancient gout remedy colchicine across FDA finish line for heart disease
Fierce Pharma
Tue, 06/20/23 - 09:35 pm
Agepha Pharma
FDA
colchicine
heart disease
Lodoco
Verve partners with Lilly on gene editing therapy for heart disease
BioPharma Dive
Thu, 06/15/23 - 10:02 am
Eli Lilly
Verve Therapeutics
heart disease
gene editing
XyloCor wraps up PhII for heart disease gene therapy, plans for pivotal trial
Endpoints
Fri, 01/27/23 - 10:31 am
XyloCor Therapeutics
gene therapy
heart disease
clinical trials
Study: Base Editing Shows Promise In Treating Heart Disease
BioSpace
Tue, 01/17/23 - 10:28 am
gene editing
base editing
heart disease
heart damage
Could Amgen's Heart Disease Candidate Generate Billions in Sales?
Motley Fool
Sun, 12/11/22 - 01:26 pm
Amgen
heart disease
olpasiran
Arrowhead Gets $250M in Royalty Deal for Cardio Drug Heading to Phase 3
MedCity News
Wed, 11/9/22 - 11:30 pm
Amgen
Arrowhead Pharmaceuticals
olpasiran
heart disease
Amgen to test new way to lower heart risk with large drug trial
BioPharma Dive
Mon, 11/7/22 - 11:00 am
Amgen
clinical trials
heart disease
olpasiran
Rocket inks Renovacor buyout to propel its heart disease gene therapy ambitions
Fierce Biotech
Tue, 09/20/22 - 10:37 am
Rocket Pharmaceuticals
M&A
gene therapy
Renovacor
heart disease
AstraZeneca axes Moderna-partnered, phase 2 heart disease drug plus a Wee inhibitor
Fierce Biotech
Fri, 07/29/22 - 10:12 am
AstraZeneca
Moderna Therapeutics
heart disease
MRNA
Wee1 inhibitors
Novartis finalizes deal to make new heart drug widely available in England
BioPharma Dive
Wed, 09/1/21 - 10:55 pm
UK
Novartis
Leqvio
heart disease
cholesterol
Bayer's Farxiga rival Kerendia scores long-awaited kidney and heart disease nod for Type 2 diabetes patients
Fierce Pharma
Fri, 07/9/21 - 11:58 pm
Bayer
finerenone
Kerendia
kidney disease
heart disease
diabetes
type 2 diabetes
Farxiga
Gene editing biotech Verve indicates a swift swerve onto Wall Street, asking for $100M IPO
Fierce Biotech
Tue, 06/1/21 - 10:50 pm
Verve Therapeutics
IPOs
gene editing
heart disease
How a New AI Algorithm Could Help in the Early Detection of Heart Disease
Xtalks
Mon, 05/17/21 - 10:43 am
artificial intelligence
Mayo Clinic
Anumana
low ejection fraction
diagnostics
heart disease
Combining AstraZeneca's 'good' cholesterol booster with PCSK9 inhibition shows promise in heart disease
Fierce Biotech
Wed, 04/21/21 - 11:23 pm
AstraZeneca
heart disease
MEDI5884
XyloCor bags $23M to expand heart disease gene therapy R&D
Fierce Biotech
Mon, 03/22/21 - 10:46 am
XyloCor Therapeutics
gene therapy
VEGF
heart disease
clinical trials
R&D
Pages
1
2
3
4
next ›
last »